Encompass Health (EHC) Projected to Post Quarterly Earnings on Thursday

Encompass Health (NYSE:EHC) is expected to be releasing its Q4 2025 results after the market closes on Thursday, February 5th. Analysts expect Encompass Health to post earnings of $1.29 per share and revenue of $1.5403 billion for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Friday, February 6, 2026 at 10:00 AM ET.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $1.23 EPS for the quarter, beating analysts’ consensus estimates of $1.19 by $0.04. Encompass Health had a net margin of 9.33% and a return on equity of 17.84%. The business had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.48 billion. During the same quarter in the prior year, the business earned $1.03 earnings per share. The firm’s revenue for the quarter was up 9.4% on a year-over-year basis. On average, analysts expect Encompass Health to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Encompass Health Trading Up 1.0%

Shares of EHC opened at $95.68 on Thursday. The stock’s 50-day moving average price is $106.81 and its 200 day moving average price is $115.14. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.76. The firm has a market capitalization of $9.63 billion, a price-to-earnings ratio of 18.09, a P/E/G ratio of 1.52 and a beta of 0.74. Encompass Health has a 12-month low of $92.53 and a 12-month high of $127.99.

Institutional Trading of Encompass Health

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Centaurus Financial Inc. boosted its position in Encompass Health by 27.9% in the 3rd quarter. Centaurus Financial Inc. now owns 3,709 shares of the company’s stock valued at $471,000 after buying an additional 809 shares during the last quarter. Danske Bank A S bought a new position in Encompass Health in the third quarter valued at about $76,000. Caitong International Asset Management Co. Ltd raised its holdings in Encompass Health by 36,200.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock worth $46,000 after purchasing an additional 362 shares during the last quarter. Advisory Services Network LLC acquired a new position in Encompass Health during the 3rd quarter valued at about $209,000. Finally, Harvest Investment Services LLC boosted its stake in shares of Encompass Health by 78.6% in the 3rd quarter. Harvest Investment Services LLC now owns 9,268 shares of the company’s stock valued at $1,177,000 after purchasing an additional 4,080 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on EHC shares. Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, January 18th. Barclays boosted their price target on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a research report on Thursday, October 30th. Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Finally, Raymond James Financial raised Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $142.86.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.